EXHIBIT 4.22 THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR UNDER ANY APPLICABLE STATE SECURITIES LAWS. ALL SUCH SECURITIES ARE SUBJECT TO...Cytomedix Inc • May 11th, 2004 • Services-commercial physical & biological research • Arkansas
REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this "AGREEMENT"), dated as of December 26, 2000, by and among CYTOMEDIX, INC., a Delaware corporation, with its headquarters located at Three Parkway North, Deerfield, Illinois 60015 (the...Registration Rights Agreement • January 17th, 2001 • Cytomedix Inc • Services-commercial physical & biological research • Illinois
AMONGAsset Purchase Agreement • January 17th, 2001 • Cytomedix Inc • Services-commercial physical & biological research • New York
Lease Page ----Lease • May 15th, 2000 • Cytomedix Inc • Services-commercial physical & biological research
WITNESSETH:Assignment and Assumption Agreement • January 17th, 2001 • Cytomedix Inc • Services-commercial physical & biological research • New York
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 21st, 2018 • Nuo Therapeutics, Inc. • Surgical & medical instruments & apparatus • Nevada
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of September 17, 2018, by and between NUO THERAPEUTICS, INC., a Delaware corporation, with headquarters located at 207A Perry Parkway, Suite 1, Gaithersburg, MD 20877 (the “Company”), and AUCTUS FUND, LLC, a Delaware limited liability company, with its address at 545 Boylston Street, 2nd Floor, Boston, MA 02116 (the “Buyer”).
For the Purchase of Shares of Common Stock ofCytomedix Inc • May 11th, 2004 • Services-commercial physical & biological research • Delaware
OFCytomedix Inc • March 29th, 2004 • Services-commercial physical & biological research • New York
SECURITY AGREEMENT THIS SECURITY AGREEMENT is executed effective as of the 26th day December, 2000, by and between Cytomedix, Inc., a Delaware corporation ("Debtor"), and TSENVI, LLC, a Delaware limited liability company, as Collateral Agent...Security Agreement • January 17th, 2001 • Cytomedix Inc • Services-commercial physical & biological research • Illinois
ARTICLE 1 EFFECTIVE DATE AND TERM OF EMPLOYMENTEmployment Agreement • May 7th, 2004 • Cytomedix Inc • Services-commercial physical & biological research • Maryland
RECITALSTermination Agreement • May 7th, 2004 • Cytomedix Inc • Services-commercial physical & biological research
REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "Agreement") is made and entered into as of March 25, 2004, by and among Cytomedix, Inc., a Delaware corporation (the "Company"), and the purchasers listed on Schedule I hereto...Registration Rights Agreement • March 29th, 2004 • Cytomedix Inc • Services-commercial physical & biological research • New York
WITNESSETH:Consulting Agreement • May 15th, 2000 • Cytomedix Inc • Services-commercial physical & biological research
ARTICLE 1Employment Agreement • December 5th, 2002 • Cytomedix Inc • Services-commercial physical & biological research • California
Exhibit 10.8 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement") is made effective as of March 3, 2000 (the "Effective Date"), between AUTOLOGOUS WOUND THERAPY, INC., a Delaware corporation (the "Company"), and DAVID C. DEMAREST...Employment Agreement • May 15th, 2000 • Cytomedix Inc • Services-commercial physical & biological research
Exhibit 10.2 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement") is made effective on this 30th day of June, 2000 (the "Effective Date"), between CYTOMEDIX, INC., a Delaware corporation (the "Company"), and KENT T. SMITH ("Executive")....Employment Agreement • August 14th, 2000 • Cytomedix Inc • Services-commercial physical & biological research
EXHIBIT 10.5 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement") is made effective as of March 3, 2000 (the "Effective Date"), between AUTOLOGOUS WOUND THERAPY, INC., a Delaware corporation (the "Company"), and JAMES A. COUR...Employment Agreement • May 25th, 2000 • Cytomedix Inc • Services-commercial physical & biological research
RECITALSSupply Agreement • January 17th, 2001 • Cytomedix Inc • Services-commercial physical & biological research • New York
SECURITIES PURCHASE AGREEMENT SECURITIES PURCHASE AGREEMENT (this "AGREEMENT"), dated as of December 26, 2000, by and among CYTOMEDIX, INC., a Delaware corporation, with headquarters located at Three Parkway North, Deerfield, Illinois 60015 (the...Securities Purchase Agreement • January 17th, 2001 • Cytomedix Inc • Services-commercial physical & biological research • Illinois
For the Purchase of Shares of Common Stock ofCytomedix Inc • May 11th, 2004 • Services-commercial physical & biological research • Delaware
OFCytomedix Inc • May 11th, 2004 • Services-commercial physical & biological research • Arkansas
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 20th, 2013 • Cytomedix Inc • Surgical & medical instruments & apparatus • Illinois
REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of February 18, 2013, by and between CYTOMEDIX, INC., a Delaware corporation, (the "Company"), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with it permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the "Purchase Agreement").
Exhibit 10.36 SECURITY AGREEMENT THIS SECURITY AGREEMENT is executed effective as of the 23rd day April, 2001, by and between Cytomedix, Inc., a Delaware corporation ("Debtor"), and First Security Bank, as Collateral Agent ("Collateral Agent"), under...Security Agreement • May 25th, 2001 • Cytomedix Inc • Services-commercial physical & biological research • Illinois
March 25, 2004 Mr. Mark Cline Dear Mark: On behalf of the Board of Directors of Cytomedix, Inc. (the "Company"), I am pleased to offer you the following compensation and other benefits on the terms and conditions set forth in this letter agreement...Cytomedix Inc • March 31st, 2004 • Services-commercial physical & biological research • Arkansas
Exhibit 4.10 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "Agreement") is made and entered into as of March 31, 2004, by and among Cytomedix, Inc., a Delaware corporation (the "Company"), and the undersigned purchaser (the...Registration Rights Agreement • May 11th, 2004 • Cytomedix Inc • Services-commercial physical & biological research • Arkansas
Exhibit 4.15 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated and effective this ___ day of October, 2003, by and among CYTOMEDIX, INC., a Delaware corporation, (the "Company"), and FEQ Investments, 111...Registration Rights Agreement • May 11th, 2004 • Cytomedix Inc • Services-commercial physical & biological research • Arkansas
EXHIBIT 4.21 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated and effective this ___ day of October, 2003, by and among CYTOMEDIX, INC., a Delaware corporation, (the "Company"), and IVC Group, 802 Grand...Registration Rights Agreement • May 11th, 2004 • Cytomedix Inc • Services-commercial physical & biological research • Arkansas
COMMON STOCK PURCHASE WARRANT NUO THERAPEUTICS, INC.Common Stock Purchase Warrant • November 20th, 2019 • Nuo Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the $[ ] senior secured promissory note to the Holder (as defined below) of even date) (the “Note”), [ ], (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Nuo Therapeutics, Inc., a Delaware corporation (the “Company”), up to [ ] shares of Common Stock (as defined below) (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain note purchase agreement dated November 15, 2019, by and among the Company and the Holder (the “Purchase Agreement”).
June 3, 2005Cytomedix Inc • June 20th, 2005 • Services-commercial physical & biological research
FIRST AMENDMENT TO CONSULTING AGREEMENT This FIRST AMENDMENT TO CONSULTING AGREEMENT (the "First Amendment") is made and entered into this 15th day of September, 2000, by and between Cytomedix, Inc., a Delaware corporation (the "Company"), and BDR...Consulting Agreement • November 20th, 2000 • Cytomedix Inc • Services-commercial physical & biological research • Delaware
EXHIBIT 10.20 CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSSION. ASTERISKS DENOTE OMISSIONS. DISTRIBUTOR AGREEMENT THIS AGREEMENT ("Agreement") is made and entered into as of this __31__ day of October,...Distributor Agreement • March 23rd, 2006 • Cytomedix Inc • Services-commercial physical & biological research • Maryland
OFCytomedix Inc • May 11th, 2004 • Services-commercial physical & biological research • New York
COMMON STOCK PURCHASE WARRANT CYTOMEDIX, INC.Common Stock Purchase • October 8th, 2010 • Cytomedix Inc • Surgical & medical instruments & apparatus
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after April __, 2011, 180 days following the issuance date of this Warrant (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Cytomedix, Inc., a Delaware corporation (the “Company”), up to ______ shares (the “Warrant Shares”) of Common Stock.
Exhibit 10.6 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated this _____ day of ____________, 2002, by and among CYTOMEDIX, INC., a Delaware corporation, (the "Company"), and each of the undersigned together...Registration Rights Agreement • December 5th, 2002 • Cytomedix Inc • Services-commercial physical & biological research • Arkansas
RECITALSRoyalty Agreement • January 17th, 2001 • Cytomedix Inc • Services-commercial physical & biological research • New York
